Overview

TDF Long Term Study

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of generic TDF from Governmental Pharmaceutical Organization (GPO) in HIV-infected children
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborators:
Bamrasnaradura Infectious Diseases Institute
Chulalongkorn University
Treatments:
Tenofovir